TipRanks
Go Ultimate55% OFF

Feedback (GZM0) AI Stock Analysis

DE:GZM0

Feedback

(Frankfurt:GZM0)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Debt-free balance sheetFeedback's zero-debt balance sheet meaningfully reduces refinancing and interest-rate risk. For a small digital-health software provider, no financial leverage preserves strategic flexibility and extends runway, allowing management to pursue restructuring or growth without fixed financing obligations.
Negative Factors
Sharp revenue declineA sustained ~25-30% revenue decline materially reduces the addressable recurring base for a SaaS business. Lower recurring sales hinder absorption of fixed operating costs, slow path to profitability, and make it difficult to leverage the company's high gross margins into improved operating results without revenue stabilization.

Feedback (GZM0) vs. iShares MSCI Germany ETF (EWG)

-75%-50%-25%0%25%50%75%100%DE:GZM0-40.63%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 2.08M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-0.3
Beta (1Y)
0.67
Revenue Growth
-28.87%
EPS Growth
31.34%
Country
Germany
Employees
29
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Feedback Business Overview & Revenue Model

Company Description

Feedback plc is a medical technology company, headquartered in London, UK, and established in 1958, that supplies specialized software and systems to individuals and organizations working within the medical imaging sector. Their product portfolio inc...

Feedback Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:GZM0 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:KOOGB:KOO72OutperformGBP 69.14M11.5217.74%―-6.51%108.62%
GB:IXIGB:IXI64NeutralGBP 25.73M-5.99-16.18%―13.04%15.88%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
GB:GDRGB:GDR49NeutralGBP 15.65M-0.89-1044.57%―65.60%74.84%
GB:COGGB:COG44NeutralGBP 15.11M-9.30-54.17%―11.86%23.81%
GB:OBDGB:OBD40UnderperformGBP 14.45M-0.27-451.74%―33.37%86.41%

* Healthcare Sector Average

Performance Comparison

-50%0%50%DE:GZM0GB:COGGB:GDRGB:IXIGB:OBDGB:KOODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:GZM0 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:GZM0Feedback plc0.06-0.04-40.63%
GB:COGCambridge Cognition Holdings28.00-5.00-15.15%
GB:GDRGenedrive plc0.970.011.25%
GB:IXIIXICO plc11.750.252.17%
GB:OBDOxford BioDynamics0.11-0.21-66.56%
GB:KOOKooth Plc190.0058.0043.94%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.